Feed/Investors/Perceptive Xontogeny Venture Fund II

Perceptive Xontogeny Venture Fund II

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

Since 2024-04-04

ROUNDS

as lead investor

LED ROUNDS · USD

$63M

across 1 round

LATEST ROUND

Funding round · $63M · 2024-04-04

CO-INVESTORS

named beside it

Rounds

[ 1 ]

The rounds this investor is named on, who it invests beside, and where it shows up.

Company	Round	Amount	Announced	Role
Neurosterix A clinical-stage biotechnology company focused on transforming neuropsychiatric care through selective allosteric modulation	Funding round Developing, 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$63M	2024-04-04	[ LEAD ]